March 19, 2026

Hoth Applies AI in Development of Candidate for KIT-Driven Cancers

Preclinical results and AI integration support progress toward regulatory submission

The Medicine Maker

March 17, 2026

Women More Likely to Survive Cancer—But Suffer More Severe Side Effects

Female patients with cancer had a 21% lower risk of death compared with male patients, yet a 12% higher risk of severe toxicities, according to results from an international study.

The ASCO Post

March 17, 2026

Manufacturing Inside the Patient

How 2025 marked biology’s shift toward engineering discipline

The Medicine Maker

March 13, 2026

Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males

Although females live longer than males on average, a large international study suggested that breast and gynecologic cancers reduce their total survival and advantage.

The ASCO Post

March 12, 2026

FDA Releases Updated Guidance on Biosimilar Development

The U.S. Food and Drug Administration (FDA) has released a new draft guidance to streamline the development of biosimilars, reflecting actions being taken by the agency to lower the cost of drugs.

The ASCO Post

March 12, 2026

Precision Therapies: The Last Mile

Why therapies still take years to reach the patients who need them

The Medicine Maker

March 11, 2026

Sudden Vision Loss: Could It Be Pituitary Apoplexy?

Case report highlights delayed treatment and persistent visual loss in a patient with pituitary adenoma

Conexiant

March 11, 2026

Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer

Discover how the early management of malnutrition and hydration in pancreatic cancer patients can enhance treatment outcomes and overall quality of life.

JADPRO

March 11, 2026

A Modular Route to RNA Delivery 

A supramolecular delivery platform forms self-assembling nanoparticles for RNA therapeutics

The Medicine Maker

March 10, 2026

Prostate Cancer: Does Taking ARPIs and Anticoagulants Together Raise Risks?

“As clinicians, we are faced with the question of choosing the best anticoagulant option for patients on a daily basis, and the complexity further increases in patients with cancer taking many other m...

The ASCO Post